Finally, it would be interesting to investigate if the effect we observed combining BMX inhibitor and Doxorubicin also applies to other conventional chemotherapeutic agents used for NB treatment as well as to targeted therapies like ALK inhibition, where the MES phenotype has been shown to play major roles in tumor resistance (22). The gene discussed is BMX; the disease is neuroblastoma.